Author Title Type [ Year(Asc)]
Filters: Keyword is Pregnancy  [Clear All Filters]
2017
Madeen EP, Löhr CV, You H, Siddens LK, Krueger SK, Dashwood RH, et al.. Dibenzo[def,p]chrysene transplacental carcinogenesis in wild-type, Cyp1b1 knockout, and CYP1B1 humanized mice. Mol Carcinog. 2017 ;56(1):163-171.
2015
Cardenas A, Koestler DC, E Houseman A, Jackson BP, Kile ML, Karagas MR, et al.. Differential DNA methylation in umbilical cord blood of infants exposed to mercury and arsenic in utero. Epigenetics. 2015 ;10(6):508-15.
Cardenas A, E Houseman A, Baccarelli AA, Quamruzzaman Q, Rahman M, Mostofa G, et al.. In utero arsenic exposure and epigenome-wide associations in placenta, umbilical artery, and human umbilical vein endothelial cells. Epigenetics. 2015 ;10(11):1054-63.
2014
Crowell SRitger, Hanson-Drury S, Williams DE, Corley RA. In vitro metabolism of benzo[a]pyrene and dibenzo[def,p]chrysene in rodent and human hepatic microsomes. Toxicol Lett. 2014 ;228(1):48-55.
2013
Shorey LE, Madeen EP, Atwell LL, Ho E, Löhr CV, Pereira CB, et al.. Differential modulation of dibenzo[def,p]chrysene transplacental carcinogenesis: maternal diets rich in indole-3-carbinol versus sulforaphane. Toxicol Appl Pharmacol. 2013 ;270(1):60-9.
Crowell SRitger, Sharma AK, Amin SG, Soelberg JJ, Sadler NC, Wright AT, et al.. Impact of pregnancy on the pharmacokinetics of dibenzo[def,p]chrysene in mice. Toxicol Sci. 2013 ;135(1):48-62.
2012
Shorey LE, Castro DJ, Baird WM, Siddens LK, Löhr CV, Matzke MM, et al.. Transplacental carcinogenesis with dibenzo[def,p]chrysene (DBC): timing of maternal exposures determines target tissue response in offspring. Cancer Lett. 2012 ;317(1):49-55.
2006
Yu Z, Löhr CV, Fischer KA, Louderback MA, Krueger SK, Dashwood RH, et al.. In utero exposure of mice to dibenzo[a,l]pyrene produces lymphoma in the offspring: role of the aryl hydrocarbon receptor. Cancer Res. 2006 ;66(2):755-62.